New Delhi: Union minister Jitendra Singh on Thursday said that after the remarkable success of India’s Covid vaccine, the upcoming Chandrayaan-3 mission will mark a quantum leap for India on the global stage. Speaking as the Chief Guest at the 11th India Alliance Annual Conclave 2023 in Hyderabad, Singh highlighted the increasing demand for India’s partnership in frontier sectors of science and technology by developed countries.
India Alliance is a unique partnership between department of biotechnology and Wellcome Trust, UK with a focus on building strong, world-class, biomedical research human resources in India at a scale where the country can make a global impact. Jitendra Singh said, the impactful journey of India Alliance over the last 15 years has strengthened the research and funding ecosystem of India and enabled successful implementations and interventions to bring impactful changes in the biomedical and clinical research ecosystem in the country.
He informed that in 2019, on completing 10 years, India Alliance launched the Team Science Grants and Clinical/Public Health Research Centres to find solutions to the problems of modern society requiring interdisciplinary and collaborative research. Highlighting the upcoming milestone, the minister acknowledged the 15-year successful partnership between DBT, Government of India, and Wellcome Trust.
Through generous funding schemes, the India Alliance has played a pivotal role in retaining research talent in India, promoting career progression and professional development for Indian researchers, and enhancing capacity building, technology, policy, and practice. The India Alliance has invested in research management capacity building, benefiting over 589 research
. Read more on livemint.com